Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081.
Kobayashi E, Nakatani E, Tanaka T, Yosuke K, Kanao H, Shiki Y, Kotani Y, Hoshiba T, Minami R, Yoshida H, Kyo S, Yorimitsu M, Yamashita T, Hasegawa T, Matsuura T, Kagami S, Fujioka T, Hirohiko T, Nishio S, Takekuma M, Mikami M, Enomoto T. Kobayashi E, et al. Among authors: shiki y. Gynecol Oncol. 2022 May;165(2):293-301. doi: 10.1016/j.ygyno.2022.02.005. Epub 2022 Feb 25. Gynecol Oncol. 2022. PMID: 35221133
Postoperative abdominal aspergilloma mimicking cervical cancer recurrence and diagnostic imaging, including F-fluorodeoxyglucose positron emission tomography, with false-positive findings.
Kobayashi E, Iwamiya T, Masaki H, Yamagata A, Isobe M, Miyake T, Shiki Y, Nakashima R, Yamasaki M. Kobayashi E, et al. Among authors: shiki y. J Obstet Gynaecol Res. 2009 Aug;35(4):808-11. doi: 10.1111/j.1447-0756.2009.01019.x. J Obstet Gynaecol Res. 2009. PMID: 19751349
A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
Mabuchi S, Isohashi F, Yokoi T, Takemura M, Yoshino K, Shiki Y, Ito K, Enomoto T, Ogawa K, Kimura T. Mabuchi S, et al. Among authors: shiki y. Gynecol Oncol. 2016 May;141(2):240-246. doi: 10.1016/j.ygyno.2016.02.011. Epub 2016 Feb 13. Gynecol Oncol. 2016. PMID: 26883141 Clinical Trial.
Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.
Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman LD. Matsuo K, et al. Among authors: shiki y. Ann Oncol. 2016 Jul;27(7):1257-66. doi: 10.1093/annonc/mdw161. Epub 2016 Apr 6. Ann Oncol. 2016. PMID: 27052653 Free article.
Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer.
Matsuo K, Yoshino K, Hiramatsu K, Banzai C, Hasegawa K, Yasuda M, Nishimura M, Sheridan TB, Ikeda Y, Shiki Y, Mabuchi S, Enomoto T, Kimura T, Fujiwara K, Roman LD, Sood AK. Matsuo K, et al. Among authors: shiki y. Obstet Gynecol. 2014 May;123(5):957-965. doi: 10.1097/AOG.0000000000000240. Obstet Gynecol. 2014. PMID: 24785846 Free PMC article.
Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).
Yoshino K, Kamiura S, Yokoi T, Nakae R, Fujita M, Takemura M, Adachi K, Wakimoto A, Nishizaki T, Shiki Y, Tsutsui T, Kanda Y, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Sawada K, Tomimatsu T, Kimura T. Yoshino K, et al. Among authors: shiki y. Cancer Chemother Pharmacol. 2017 Dec;80(6):1239-1247. doi: 10.1007/s00280-017-3468-5. Epub 2017 Oct 28. Cancer Chemother Pharmacol. 2017. PMID: 29080971 Clinical Trial.
56 results